Familial clustering of HCV-related hepatocellular carcinoma (HCC)

被引:0
|
作者
Pasta, L
Bevacqua, EA
Marrone, C
d'Amico, M
D'Amico, G
Pagliaro, L
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:A761 / A761
页数:1
相关论文
共 50 条
  • [41] Hepatitis C Virus (HCV) Diagnosis and Clinical Outcomes of Patients With HCV-Related Hepatocellular Carcinoma (HCC): A Comparative Study of Asians Versus Non-Asians
    Yip, Benjamin
    Wantuck, James M.
    Kim, Lily H.
    Wong, Robert J.
    Ahmed, Aijaz
    Garcia, Gabriel
    Nguyen, Mindie H.
    GASTROENTEROLOGY, 2013, 144 (05) : S953 - S953
  • [42] Pretransplantation Direct-acting Antivirals Provides a Safe and Effective without Increase Recurrence of Hepatocellular Carcinoma in HCV-related HCC Patients
    Yin, S. M.
    Chen, C. L.
    Lin, C. C.
    Wang, C. C.
    Wang, S. H.
    Liu, Y. W.
    Yong, C. C.
    Lin, T. L.
    Li, W. F.
    Lin, Y. H.
    Chan, Y-C
    Yeh, C-S
    TRANSPLANTATION, 2017, 101 (05) : 42 - 43
  • [43] Alpha interferon treatment may prevent hepatocellular carcinoma in HCV-related liver cirrhosis
    Mazzella, G
    Accogli, E
    Sottili, S
    Festi, D
    Orsini, M
    Salzetta, A
    Novelli, V
    Cipolla, A
    Fabbri, C
    Pezzoli, A
    Roda, E
    JOURNAL OF HEPATOLOGY, 1996, 24 (02) : 141 - 147
  • [44] Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma
    Toraih, Eman A.
    Ellawindy, Alia
    Fala, Salma Y.
    Al Ageeli, Essam
    Gouda, Nawal S.
    Fawzy, Manal S.
    Hosny, Somaya
    BIOMEDICINE & PHARMACOTHERAPY, 2018, 102 : 653 - 669
  • [45] lncRNA-HEIH in serum and exosomes as a potential biomarker in the HCV-related hepatocellular carcinoma
    Zhang, Chun
    Yang, Xi
    Qi, Quan
    Gao, Yuhai
    Wei, Qiang
    Han, Shuwen
    CANCER BIOMARKERS, 2018, 21 (03) : 651 - 659
  • [46] Systematic Review: Impact of Interferon-based Therapy on HCV-related Hepatocellular Carcinoma
    Ching-Sheng Hsu
    You-Chen Chao
    Hans Hsienhong Lin
    Ding-Shinn Chen
    Jia-Horng Kao
    Scientific Reports, 5
  • [47] Serum VEGF as a Tumor Marker for Patients With HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma
    Mukozu, Takanori
    Nagai, Hidenari
    Kobayashi, Koujirou
    Ogino, Yu
    Matui, Daigo
    Kanekawa, Takenori
    Kogame, Michio
    Takayama, Ryuji
    Kanayama, Masahiro
    Wakui, Noritaka
    Shinohara, Mie
    Shinohara, Masao
    Ishii, Koji
    Igarashi, Yoshinori
    Sumino, Yasukiyo
    GASTROENTEROLOGY, 2012, 142 (05) : S980 - S980
  • [48] PREDICTIVE FACTORS OF DISTANT RECURRENCE OF HCV-RELATED HEPATOCELLULAR CARCINOMA AFTER RADIOFREQUENCY ABLATION
    Beppu, Tetsuya
    Shiraki, Katsuya
    Sugimoto, Kazushi
    Kusagawa, Satoko
    Nojiri, Keiichiro
    Tanaka, Junichiro
    Yamamoto, Norihiko
    Tameda, Masahiko
    Takei, Yoshiyuki
    HEPATOLOGY, 2010, 52 (04) : 1191A - 1192A
  • [49] LNCRNA H19 Is Increased In Hepatocellular Carcinoma With Underlying Hcv-Related Cirrhosis
    Garcia-Valdecasas, Marta
    Gil-Gomez, Antonio
    Rojas, Angela
    Gallego-Duran, Rocio
    Munoz, Rocio
    Fombuena, Blanca
    Pastor-Ramirez, Helena
    Del Campo, Jose A.
    Vilar-Gomez, Eduardo
    Ampuero, Javier
    Romero-Gomez, Manuel
    HEPATOLOGY, 2016, 64 : 970A - 970A
  • [50] The management strategies for HCV-related early hepatocellular carcinoma: A health decision analysis.
    Moriguchi, H
    HEPATOLOGY, 2002, 36 (04) : 710A - 710A